ALGN
ALIGN TECHNOLOGY INC
NASDAQ · Healthcare · Medical - Devices · US
$164.54
+8.55%Year over year
Reported trailing growth
- Revenue
- +4.4%
- EBITDA
- -8.7%
- EBIT
- +16.9%
- EPS
- +33.3%
- Free cash flow
- +44.1%
- Operating cash flow
- +14.3%
Forward estimates
Based on analyst estimates
- Revenue
- +0.7%
- EBITDA
- +69.9%
- EPS
- +73.5%
Three-year CAGR
- Revenue
- +2.6%
- EBITDA
- +1.8%
- EBIT
- -1.4%
- Net income
- +4.3%
- EPS
- +7.0%
- Free cash flow
- +21.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026